Home › Von Hippel-Lindau Syndrome › Washington
Von Hippel-Lindau Syndrome clinical trials in Washington, DC
3 studies for Von Hippel-Lindau Syndrome are looking for participants at sites in and around Washington (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Belzutifan/MK-6482 for the Treatment of Advanced Pheochromocytoma/Paraganglioma (PPGL), Pancreatic Neuroendocrine Tumor (pNET), Von Hippel-Lindau (VHL) Disease-Associated Tumors, Advanced Gastrointestinal Stromal Tumor (wt GIST), or Solid Tumors With HIF-2α Related Genetic Alterations (MK-6482-015)
RecruitingPhase 2
- National Institutes of Health ( Site 0125), Bethesda · 7 mi away
National Eye Institute Biorepository for Retinal Diseases
RecruitingObservational studyHealthy volunteers welcome
- National Institutes of Health Clinical Center, Bethesda · 7 mi away
Natural History and Management of Von Hippel-Lindau (VHL) Associated Pancreatic Neuroendocrine Tumors
RecruitingPhase 2
- National Institutes of Health Clinical Center, Bethesda · 7 mi away
About Von Hippel-Lindau Syndrome
Von Hippel-Lindau syndrome (VHL) is a rare genetic disease that causes tumors and cysts to grow in your body. Learn about symptoms and treatment.
More about Von Hippel-Lindau Syndrome on MedlinePlus
Von Hippel-Lindau Syndrome trials in other cities
Other studies in Washington
- Cancer (all types)60 studies
- Non-Small Cell Lung Cancer55 studies
- Breast Cancer44 studies
- Metastatic Cancer44 studies
- Lung Cancer41 studies
- Prostate Cancer39 studies
- Obesity34 studies
- Colorectal Cancer28 studies
- Cardiovascular Disease27 studies
- Bladder Cancer26 studies
- Ovarian Cancer25 studies
- Lymphoma23 studies
From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.